Total peripheral conductance mediates antihypertensive effect of nonpeptide mixed endothelin receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats

American Journal of Hypertension

Volumn 12, Issue 8 I, 1999, Pages 845-848

  Yu, M ^a   Gopalakrishnan, V ^a   McNeill, J R ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Blood pressure; Cardiac output; DOCA salt hypertension; Endothelin; Endothelin antagonist; Hemodynamics; Total peripheral resistance

Indexed keywords

BOSENTAN; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VESSEL TONE; CONTROLLED STUDY; EXPERIMENTAL MODEL; HEART OUTPUT; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE;

EID: 0032836146     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00055-2     Document Type: Article

References (14)

1. J.S. Li R. Lariviere E.L. Schiffrin Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats Hypertension 24 1994 183 188
2. R. Lariviere G. Thibault E.L. Schiffrin Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats Hypertension 21 1993 294 300
3. A receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension Br J Pharmacol 114 1995 925 930
4. M. Yu V. Gopalakrishnan J.R. McNeill Hemodynamic effects of a selective endothelin-A receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats J Cardiovasc Pharmacol 31 suppl 1 1998 S262 S264
5. J.E. Bird S. Moreland T.L. Waldron Antihypertensive effects of a novel endothelin-A receptor antagonist in rats Hypertension 25 1995 1191 1195
6. S.M. Balakrishnan H.D. Wang V. Gopalakrishnan Effect of an endothelin antagonist on hemodynamic responses to angiotensin II Hypertension 28 1996 806 809
7. M. Clozel V. Breu G.A. Grey Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist J Pharmacol Exp Ther 270 1994 228 235
8. J. Doucet W. Gonzalez J.B. Michel Endothelin antagonists in salt-dependent hypertension associated with renal insufficiency J Cardiovasc Pharmacol 27 1996 643 651
9. M. Gellai T. Fletcher M. Pullen Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat Am J Physiol 271 1996 R254 R261
10. 1,3,11,15]endothelin-1 by BQ-123 in the anaesthetized rat Br J Pharmacol 107 1992 912 918
11. A) receptor antagonist in conscious rats J Cardiovasc Pharmacol 20 1992 940 948
12. D.M. Pollock B.J. Divish T.J. Opgenorth Stimulation of endogenous endothelin release in the anesthetized rat J Cardiovasc Pharmacol 22 suppl 8 1993 S295 S298
13. M.K. Bazil C. Krulan R.L. Webb Telemetric monitoring of cardiovascular parameters in conscious spontaneously hypertensive rats J Cardiovasc Pharmacol 22 1993 897 905
14. T. Nabika Y. Nara K. Ikeda Genetic heterogeneity of the spontaneouly hypertensive rat Hypertension 18 1991 12 16